These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 27036617)
1. A high-throughput screening-compatible homogeneous time-resolved fluorescence assay measuring the glycohydrolase activity of human poly(ADP-ribose) glycohydrolase. Stowell AI; James DI; Waddell ID; Bennett N; Truman C; Hardern IM; Ogilvie DJ Anal Biochem; 2016 Jun; 503():58-64. PubMed ID: 27036617 [TBL] [Abstract][Full Text] [Related]
2. A nonradiometric, high-throughput assay for poly(ADP-ribose) glycohydrolase (PARG): application to inhibitor identification and evaluation. Putt KS; Hergenrother PJ Anal Biochem; 2004 Oct; 333(2):256-64. PubMed ID: 15450800 [TBL] [Abstract][Full Text] [Related]
3. Discovery and structure-activity relationships of modified salicylanilides as cell permeable inhibitors of poly(ADP-ribose) glycohydrolase (PARG). Steffen JD; Coyle DL; Damodaran K; Beroza P; Jacobson MK J Med Chem; 2011 Aug; 54(15):5403-13. PubMed ID: 21692479 [TBL] [Abstract][Full Text] [Related]
4. Discovery of novel poly(ADP-ribose) glycohydrolase inhibitors by a quantitative assay system using dot-blot with anti-poly(ADP-ribose). Okita N; Ashizawa D; Ohta R; Abe H; Tanuma S Biochem Biophys Res Commun; 2010 Feb; 392(4):485-9. PubMed ID: 20079708 [TBL] [Abstract][Full Text] [Related]
5. A quantitative assay reveals ligand specificity of the DNA scaffold repair protein XRCC1 and efficient disassembly of complexes of XRCC1 and the poly(ADP-ribose) polymerase 1 by poly(ADP-ribose) glycohydrolase. Kim IK; Stegeman RA; Brosey CA; Ellenberger T J Biol Chem; 2015 Feb; 290(6):3775-83. PubMed ID: 25477519 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADP‑ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells. Feng X; Koh DW Int J Oncol; 2013 Feb; 42(2):749-56. PubMed ID: 23254695 [TBL] [Abstract][Full Text] [Related]
11. Spatial and functional relationship between poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in the brain. Poitras MF; Koh DW; Yu SW; Andrabi SA; Mandir AS; Poirier GG; Dawson VL; Dawson TM Neuroscience; 2007 Aug; 148(1):198-211. PubMed ID: 17640816 [TBL] [Abstract][Full Text] [Related]
12. New Insights into the Roles of NAD+-Poly(ADP-ribose) Metabolism and Poly(ADP-ribose) Glycohydrolase. Tanuma S; Sato A; Oyama T; Yoshimori A; Abe H; Uchiumi F Curr Protein Pept Sci; 2016; 17(7):668-682. PubMed ID: 27817743 [TBL] [Abstract][Full Text] [Related]
13. Specific killing of DNA damage-response deficient cells with inhibitors of poly(ADP-ribose) glycohydrolase. Gravells P; Grant E; Smith KM; James DI; Bryant HE DNA Repair (Amst); 2017 Apr; 52():81-91. PubMed ID: 28254358 [TBL] [Abstract][Full Text] [Related]
14. Global analysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells. Frizzell KM; Gamble MJ; Berrocal JG; Zhang T; Krishnakumar R; Cen Y; Sauve AA; Kraus WL J Biol Chem; 2009 Dec; 284(49):33926-38. PubMed ID: 19812418 [TBL] [Abstract][Full Text] [Related]
15. Visualization of poly(ADP-ribose) bound to PARG reveals inherent balance between exo- and endo-glycohydrolase activities. Barkauskaite E; Brassington A; Tan ES; Warwicker J; Dunstan MS; Banos B; Lafite P; Ahel M; Mitchison TJ; Ahel I; Leys D Nat Commun; 2013; 4():2164. PubMed ID: 23917065 [TBL] [Abstract][Full Text] [Related]
16. Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors. Brosey CA; Houl JH; Katsonis P; Balapiti-Modarage LPF; Bommagani S; Arvai A; Moiani D; Bacolla A; Link T; Warden LS; Lichtarge O; Jones DE; Ahmed Z; Tainer JA Prog Biophys Mol Biol; 2021 Aug; 163():171-186. PubMed ID: 33636189 [TBL] [Abstract][Full Text] [Related]
17. Expression of poly(ADP-ribose) glycohydrolase in wild-type and PARG-110 knock-out retina. Sahaboglu A; Bolz S; Löwenheim H; Paquet-Durand F Adv Exp Med Biol; 2014; 801():463-9. PubMed ID: 24664732 [TBL] [Abstract][Full Text] [Related]
18. An assay to measure poly(ADP ribose) glycohydrolase (PARG) activity in cells. James DI; Durant S; Eckersley K; Fairweather E; Griffiths LA; Hamilton N; Kelly P; O'Connor M; Shea K; Waddell ID; Ogilvie DJ F1000Res; 2016; 5():736. PubMed ID: 27610220 [TBL] [Abstract][Full Text] [Related]
19. PARG Inhibitors and Functional PARG Inhibition Models. Sasaki Y; Hozumi M; Fujimori H; Murakami Y; Koizumi F; Inoue K; Masutani M Curr Protein Pept Sci; 2016; 17(7):641-653. PubMed ID: 27817742 [TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) - Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy. Harrision D; Gravells P; Thompson R; Bryant HE Front Mol Biosci; 2020; 7():191. PubMed ID: 33005627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]